Lymphoma & Plasma Cell Disorders
News
First CAR T-cell therapy for multiple myeloma: Abecma
“The results of this trial represent a true turning point in the treatment of this disease.”
News
Poor survival with COVID in patients who have had HSCT
News
FDA scrutinizes cancer therapies granted accelerated approval
News
High-dose chemo no better than standard dose for B-cell lymphoma
News
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
News
‘Phenomenal’ results with CAR T cells in R/R multiple myeloma
Conference Coverage
CAR T-cell products shine in real-world setting, reveal new insights
Real-world CAR-T experience provides new insights for predicting outcomes in patients with DLBCL.
Article
How has the pandemic affected rural and urban cancer patients?
News
FDA okays new CAR T-cell treatment for large B-cell lymphomas
Article
COVID-19 vaccination in cancer patients: NCCN outlines priorities
Recommended timing of vaccination varies based on cancer and treatment type.
